Askarova Fotima Kudratovna (1)
Cervicitis is a common inflammatory condition of the uterine cervix, frequently asymptomatic, and associated with sexually transmitted infections (notably Chlamydia trachomatis and Neisseria gonorrhoeae), as well as Mycoplasma genitalium, Trichomonas vaginalis, and dysbiosis. This review synthesizes recent evidence for clinicians and researchers, detailing clinical presentation, diagnostic methods (speculum exam, microscopy, NAAT/PCR, culture), and treatment strategies adapted to antimicrobial resistance trends. Special emphasis is placed on Uzbekistan: the availability of laboratory diagnostics, empiric therapy patterns in urban versus rural settings, and antimicrobial stewardship. We discuss the shift from azithromycin to doxycycline-first strategies for non-pregnant adults, resistance-guided therapy for M. genitalium, partner management, and prevention. We outline implementation priorities for Uzbekistan’s health system: expanding NAAT access, integrating cervicitis into reproductive health programs, strengthening AMR surveillance, and public health education to reduce reproductive sequelae.
1. Centers for Disease Control and Prevention (CDC). Sexually Transmitted Infections Treatment Guidelines – Cervicitis. 2021.
2. World Health Organization (WHO). Global Prevalence of Chlamydia and Gonorrhea. 2024.
3. Vodstrcil LA, et al. Trends in infections detected in women with cervicitis over a decade. Front Reprod Health. 2025;7:1539186.
4. Manhart LE, et al. Mycoplasma genitalium: diagnostic and therapeutic challenges. Emerg Infect Dis. 2022;28(8):1460–1469.
5. Ministry of Health of the Republic of Uzbekistan. National Strategy for Reproductive Health 2025–2030. Tashkent, 2024.
6. Abdullaeva M.K., Akhmedova S.N. Epidemiological structure of cervicitis in Uzbekistan: a 3-year analysis. Journal of Obstetrics and Gynecology of Uzbekistan. 2023; 4(2): 45–53.
7. RSSPMCOG Clinical Report. Antimicrobial therapy outcomes in cervicitis patients, 2024. Tashkent, 2025.
8. WHO Regional Office for Europe. Antimicrobial Resistance Surveillance in Central Asia. 2024.
9. Samarkand State Medical University. Cervicitis microbiological analysis, 2024 internal study report.
10. Ministry of Health of Uzbekistan. Infectious Disease Surveillance Annual Report 2024.
11. Askarova F., Homidova S. PLACENTAL INSUFFICIENCY: BLOOD AND BIOCHEMISTRY PARAMETERS DEPENDING ON THE METHOD OF TREATMENT //International Bulletin of Medical Sciences and Clinical Research. – 2023. – Т. 3. – №. 2. – С. 74-78.
12. Закирова, Н., Рузиева, Н., Лутфуллаев, У., Зияева , З., Аскарова, Ф., & Кенжаева , У. (2022). Состояние репродуктивного здоровья и размеры таза у девушек, проживающих в условиях акселерации (обзор литературы). Журнал вестник врача, 1(1), 62–65. извлечено от https://inlibrary.uz/index.php/doctors_herald/article/view/5394
13. Askarova F. K. THE ROLE OF VITAMINS IN IRON DEFICIENCY IN PREGNANT WOMEN //World Bulletin of Public Health. – 2021. – Т. 4. – С. 99-102.
14. Аскарова Ф. К., Нодиржонович Я. ВЛИЯНИЕ МЕТАБОЛИЧЕСКИХ ИЗМЕНЕНИЙ НА СЕРДЕЧНО-СОСУДИСТУЮ СИСТЕМУ ЖЕНЩИН //Eurasian Journal of Medical and Natural Sciences. – 2024. – Т. 4. – №. 4-1. – С. 150-155.